The D-Dimer to Albumin Ratio Could Predict Hospital Readmission Within One Year in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Li Li,Qinsheng Feng,Chunsong Yang

DOI: https://doi.org/10.2147/copd.s481483

2024-12-04

International Journal of COPD

Abstract:Li Li, Qinsheng Feng, Chunsong Yang Department of Respiratory and Critical Care Medicine, Baise People's Hospital, Baise, Guangxi, 533099, People's Republic of China Correspondence: Li Li, Department of Respiratory and Critical Care Medicine, Baise People's Hospital, No. 8, Chengxiang Road, Youjiang District, Baise, Guangxi, 533099, People's Republic of China, Tel +86-0776-2851142, Email Purpose: To explore the association of D-dimer-to-albumin ratio (DAR) with hospital readmission within one year in patients with acute exacerbation chronic obstructive pulmonary disease (AECOPD). Patients and Methods: From January 2019 to October 2022, 509 patients with COPD were enrolled in Baise People's Hospital for this retrospective cohort study. Baseline data and blood samples were collected, and patients were followed up for one year after inclusion. The AECOPD hospital readmission within one year was the outcome. Receiver operating characteristics (ROC) curves were conducted to determine the prognostic performance of DAR for predicting readmission within one year. The relationships between DAR, neutrophil-to-lymphocyte ratio (NLR), and AECOPD hospital readmission were conducted using univariate and multivariate logistic regression models, with odds ratios (ORs) and 95% confidence intervals (CIs). The relationship was further explored in different modified Medical Research Council (mMRC), COPD assessment test (CAT), COPD course, pneumonia, glucocorticoid, antibiotic subgroups. Results: Totally, 117 (22.99%) COPD patients were hospital readmission due to AECOPD. The area under the curve (AUC) for the DAR was 0.726. DAR ≥ 2.21 (OR=1.80, 95% CI: 1.05– 3.17) was associated with elevated odds of AECOPD hospital readmission within one year. DAR ≥ 2.21 was related to increased odds of AECOPD hospital readmission in patients of those mMRC ≥ 2, CAT > 20, COPD course < 10 years, and pneumonia. NLR ≥ 3.69 was associated with higher odds of AECOPD hospital readmission in patients of those mMRC ≥ 2 and COPD course ≥ 10 years. Conclusion: In patients with AECOPD, DAR showed a better predictive value in predicting the risk of hospital readmission in patients with AECOPD within one year. The findings of our study might help identify patients with a high risk of readmission within one year and provide timely treatment to prevent the reoccurrence of AECOPD. Keywords: acute exacerbation, chronic obstructive pulmonary disease, readmission, D-dimer to albumin ratio Chronic obstructive pulmonary disease (COPD) is a prevalent and debilitating respiratory condition, characterized by persistent airflow restriction and frequent exacerbations. 1 COPD ranks as the third leading cause of mortality globally, resulting in over 3 million deaths annually. 2,3 In China, COPD affects approximately 13.6% of adults aged over 40 years, imposing a significant disease burden. 4 Acute exacerbation of COPD (AECOPD), a condition in which respiratory symptoms increase beyond the level of daily variation and necessitate changes in treatment, is a major contributor to hospitalizations and increased healthcare costs. 5 The incidence of acute exacerbation could hasten disease progression, diminish quality of life, and increase mortality risk. 6 Approximately 20% of patients undergo hospital readmission for AECOCP within 30 days after admission. 7,8 And more than 50% of patients experience at least one readmission for acute exacerbation within 1 year after discharge, with frequent exacerbation correlating with progressive COPD severity and increased mortality risk. 9,10 Despite advancements in COPD management, the prediction and prevention of AECOPD hospital readmissions remain a challenge. Identifying indicators that can predict AECOPD exacerbation and subsequent hospital readmission is crucial for improving patient prognosis. The D-dimer-to-albumin ratio (DAR) is a sensitive indicator of hypercoagulability, inflammation, and nutritional status, and has been shown to have prognostic value in COVID-19 and gastric cancer. 11,12 DAR may also be linked to disease severity and prognosis in patients with COPD. COPD is a chronic inflammatory disease characterized by a hypercoagulable state. 13 And an interactive relationship exists between coagulation and inflammation. 14,15 D-dimer not only reflects the activation of the coagulation system, but also promotes the release of inflammatory factors and contributes to the inflammatory response. 16,17 In stable COPD, elevated D-dimer levels are associated with increased disease severity and mortality risk. 18,19 During acute exacerbations, high D-dimer levels are linked to an increased risk of hospitalized and one-ye -Abstract Truncated-

respiratory system